George M Eliopoulos
Overview
Explore the profile of George M Eliopoulos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
2279
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rice L, Eliopoulos G
Antimicrob Agents Chemother
. 2020 Dec;
65(3).
PMID: 33361289
Since its inaugural issue nearly half a century ago, has served as a premier source for reports on scientific and clinical advances in the field of antimicrobial chemotherapy. As a...
2.
Hirsch E, Brigman H, Zucchi P, Chen A, Anderson J, Eliopoulos G, et al.
J Glob Antimicrob Resist
. 2020 May;
22:689-694.
PMID: 32353524
Background: Despite availability of ceftolozane-tazobactam (C/T) and ceftazidime-avibactam (CZA) for several years, the individual spectrum of activity of each agent may not be widely known. We compared the activity of...
3.
Kang A, Smith K, Berg A, Truelson K, Eliopoulos G, McCoy C, et al.
Antimicrob Agents Chemother
. 2018 Jan;
62(4).
PMID: 29339396
Apramycin, an aminocyclitol aminoglycoside, was rapidly bactericidal against In a neutropenic murine thigh infection model, treatment-associated CFU reductions of >4 log per thigh were observed for all exposures for which...
4.
Kang A, Smith K, Eliopoulos G, Berg A, McCoy C, Kirby J
Diagn Microbiol Infect Dis
. 2017 Mar;
88(2):188-191.
PMID: 28341099
The in vitro activity of apramycin was compared to that of amikacin, gentamicin, and tobramycin against multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Apramycin demonstrated an MIC/MIC...
5.
Hirsch E, Zucchi P, Chen A, Raux B, Kirby J, McCoy C, et al.
Antimicrob Agents Chemother
. 2016 Feb;
60(5):3138-40.
PMID: 26883704
Increasing resistance among Gram-negative uropathogens limits treatment options, and susceptibility data for multidrug-resistant isolates are limited. We assessed the activity of five oral agents against 91 multidrug-resistant Gram-negative urine isolates...
6.
Hirsch E, Raux B, Zucchi P, Kim Y, McCoy C, Kirby J, et al.
Int J Antimicrob Agents
. 2015 Oct;
46(6):642-7.
PMID: 26498988
Fosfomycin is recommended as first-line treatment for acute uncomplicated cystitis in women. It has demonstrated in vitro activity against a variety of pathogens; however, a paucity of data are available...
7.
Cameron D, Mortin L, Rubio A, Mylonakis E, Moellering Jr R, Eliopoulos G, et al.
Virulence
. 2015 Apr;
6(2):127-31.
PMID: 25830650
Daptomycin resistance (DAP(R)) in Staphylococcus aureus is associated with mutations in genes that are also implicated in staphylococcal pathogenesis. Using a laboratory-derived series of DAP exposed strains, we showed a...
8.
Chalkias S, Doweiko J, Eliopoulos G
Open Forum Infect Dis
. 2015 Mar;
1(1):ofu008.
PMID: 25734082
Infection with human T-lymphotropic virus type 1 (HTLV-1) can be associated with hematologic malignancy, inflammatory syndromes, or infectious complications. Herein, we bring attention to HTLV-1 infection complications as we discuss...
9.
Rice L, Eliopoulos G, Jacoby G
Antimicrob Agents Chemother
. 2014 May;
58(7):3583-4.
PMID: 24798286
No abstract available.
10.
Cameron D, Ward D, Kostoulias X, Howden B, Moellering Jr R, Eliopoulos G, et al.
J Infect Dis
. 2012 Apr;
205(11):1677-87.
PMID: 22492855
The genetic mechanisms that contribute to reduced susceptibility to vancomycin in Staphylococcus aureus are complex and heterogeneous. In addition, debate is emerging as to the true effect of reduced susceptibility...